BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6870994)

  • 1. Cholesterol content as a possible determinant in the removal of chylomicron triglyceride by the liver.
    Vessby B; Ontko JA
    Atherosclerosis; 1983 May; 47(2):111-22. PubMed ID: 6870994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons.
    Redgrave TG
    J Clin Invest; 1970 Mar; 49(3):465-71. PubMed ID: 5415674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chylomicron catabolism differs between Hooded and albino laboratory rats.
    Jeffery F; Redgrave TG
    J Lipid Res; 1982 Jan; 23(1):154-60. PubMed ID: 7057104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of biliary secretion of chylomicron remnant cholesterol (esters) in the rat.
    van Dijk MC; Pieters M; van Berkel TJ
    Eur J Biochem; 1993 Feb; 211(3):781-7. PubMed ID: 8436135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma clearance of chylomicrons from butterfat is not dependent on saturation: studies with butterfat fractions and other fats containing triacylglycerols with low or high melting points.
    Phan CT; Mortimer BC; Martins IJ; Redgrave TG
    Am J Clin Nutr; 1999 Jun; 69(6):1151-61. PubMed ID: 10357733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylomicron remnant particle formation in vivo in hepatectomised rat.
    Vost A; Pocock DM; Pleet S
    Adv Exp Med Biol; 1977; 82():139-41. PubMed ID: 920347
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of Triton WR-1339, protamine sulfate and heparin on the plasma removal of emulsion models of chylomicrons and remnants in rats.
    Hirata MH; Oliveira HC; Quintão EC; Redgrave TG; Maranhão RC
    Biochim Biophys Acta; 1987 Feb; 917(2):344-6. PubMed ID: 3801508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of radiolabelled chylomicron lipids in intact and hepatectomized rats.
    Belcher JD; Rudel LL; Waite M
    Comp Biochem Physiol B; 1985; 81(1):87-96. PubMed ID: 4017550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
    Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
    Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.
    Rensen PC; van Berkel TJ
    J Biol Chem; 1996 Jun; 271(25):14791-9. PubMed ID: 8662966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits.
    Ross AC; Zilversmit DB
    J Lipid Res; 1977 Mar; 18(2):169-81. PubMed ID: 191549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cholesteryl ester transfer from chylomicrons and other plasma lipoproteins to aortic intima media of cholesterol-fed rabbits.
    Stender S; Zilversmit DB
    Arteriosclerosis; 1982; 2(6):493-9. PubMed ID: 7181736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake.
    Hussain MM; Mahley RW; Boyles JK; Fainaru M; Brecht WJ; Lindquist PA
    J Biol Chem; 1989 Jun; 264(16):9571-82. PubMed ID: 2722852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons.
    Oliveira HC; Hirata MH; Redgrave TG; Maranhão RC
    Biochim Biophys Acta; 1988 Feb; 958(2):211-7. PubMed ID: 3337836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disappearance from the circulation of chylomicrons obtained from control and diabetic rats.
    Feingold KR; Lear SR; Felts JM
    Endocrinology; 1987 Aug; 121(2):475-80. PubMed ID: 3595526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat.
    Redgrave TG; Small DM
    J Clin Invest; 1979 Jul; 64(1):162-71. PubMed ID: 221542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma kinetics of an artificial emulsion resembling chylomicrons in patients with chronic lymphocytic leukemia.
    Sakashita AM; Bydlowski SP; Chamone DA; Maranhão RC
    Ann Hematol; 2000 Dec; 79(12):687-90. PubMed ID: 11195006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
    Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
    Bowler A; Redgrave TG; Mamo JC
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of cholesterol-rich chylomicroms. Mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart.
    Fielding CJ
    J Clin Invest; 1978 Jul; 62(1):141-51. PubMed ID: 659628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.